BNP Paribas Financial Markets
KRON

BNP Paribas Financial Markets’s Kronos Bio KRON Stock Holding History

BNP Paribas Financial Markets’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-342
Closed -$282 – 5571
2025
Q1 		$282 Sell
342
-129
-27% -$124 ﹤0.01% 5188
2024
Q4 		$447 Buy
+471
New +$444 ﹤0.01% 5183

BNP Paribas Financial Markets's KRON Position: Q2 2025 in Review

BNP Paribas Financial Markets sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 342 shares — an estimated $282 sold.

BNP Paribas Financial Markets first reported a position in KRON in Q4 2024 and held it in 2 quarters. The position peaked at $447 in Q4 2024. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • BNP Paribas Financial Markets reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 342 Kronos Bio shares in Q2 2025, an estimated $282.
  • BNP Paribas Financial Markets first reported a position in Kronos Bio in Q4 2024 and held it in 2 quarters.
  • BNP Paribas Financial Markets's Kronos Bio position peaked at $447 in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.